NCT02493569

Brief Summary

The purpose of the study is to study the epidemic features and diagnosis of female breast cancer, especially the diagnosis and treatment of breast cancer.The disease-free survival (DFS) and the total survival time(OS) of the breast cancer patients will also be studied.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,000

participants targeted

Target at P75+ for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 9, 2015

Completed
1.2 years until next milestone

Study Start

First participant enrolled

October 1, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
Last Updated

August 10, 2016

Status Verified

August 1, 2016

Enrollment Period

1 year

First QC Date

July 7, 2015

Last Update Submit

August 9, 2016

Conditions

Breast Cancer

Keywords

Breast cancer, hospital, epidemiology, diagnosis, treatment

Outcome Measures

Primary Outcomes (1)

  • Overall five-year survival for the female breast cancer patients

    5 years

Study Arms (1)

Epidemiology breast cancer patients

Observe the features of clinical diagnosis and treatment for female breast cancer patients

Procedure: The radical mastectomy of breast cancer

Interventions

The radical mastectomy of breast cancerPROCEDURE

The radical mastectomy of breast cancer could be used for the treatment of breast cancer during the observation.

Epidemiology breast cancer patients

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The female breast cancer patients in Shaanxi Province of China, those study population shoud be the hospitalized patients who are confirmed of the primary breast cancer histologically, moreover, the date of the inpatients are within the month we chosen and those inpatients should have been received or under receiving the relevant treatment including surgical treatment, chemotherapy and radiotherapy.

You may qualify if:

  • Female patients;
  • The hospitalized patients who are confirmed of the primary breast cancer histologically;
  • The date of the inpatients are within the month we chosen;
  • Patients who are within the month we chosen have been received or under receiving the relevant treatment including surgical treatment, chemotherapy and radiotherapy.

You may not qualify if:

  • Male breast cancer patients;
  • Patients with breast cancer who are not under the chosen time;
  • Non hospitalized patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Breast NeoplasmsDisease

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Yu Ren, MD,PhD

    First Affiliated Hospital Xi'an Jiaotong University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yu Ren, MD,PhD

CONTACT

13700222161renyyyyy@126.com

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2015

First Posted

July 9, 2015

Study Start

October 1, 2016

Primary Completion

October 1, 2017

Last Updated

August 10, 2016

Record last verified: 2016-08